Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.
作者信息
Curtis Michael, Berk Justin, Larney Sarah, Rich Josiah D, Stoové Mark
机构信息
Behaviours and Health Risks Program, Burnet Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Monash Addition Research Centre, Monash University, Melbourne, VIC, Australia.
Warren Alpert Medical School, Brown University, Providence, RI, USA; Rhode Island Department of Corrections, Cranston, RI, USA.
出版信息
Int J Drug Policy. 2022 Feb;100:103572. doi: 10.1016/j.drugpo.2021.103572. Epub 2022 Jan 5.
Abstract
摘要
相似文献
1
Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison.监禁期间阿片类激动剂治疗方式的转换：出狱期间及出狱后支持需求增加的新标志。
Int J Drug Policy. 2022 Feb;100:103572. doi: 10.1016/j.drugpo.2021.103572. Epub 2022 Jan 5.
2
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.加拿大安大略省患有阿片类药物使用障碍（OUD）的联邦监狱服刑人员的阿片类激动剂治疗（OAT）经历与释放计划：一项混合方法研究
BMC Public Health. 2022 Mar 4;22(1):436. doi: 10.1186/s12889-022-12685-0.
3
Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis.在澳大利亚维多利亚州，一批在入狱前有注射吸毒史的男性囚犯出狱后停止使用阿片类激动剂治疗：一项离散时间生存分析。
Drug Alcohol Depend. 2023 Jan 1;242:109730. doi: 10.1016/j.drugalcdep.2022.109730. Epub 2022 Dec 7.
4
Long-acting injectable buprenorphine - 'best practice' opioid agonist therapy for Australian prisoners.长效注射丁丙诺啡- 澳大利亚囚犯阿片类激动剂治疗的“最佳实践”。
Australas Psychiatry. 2022 Aug;30(4):498-502. doi: 10.1177/10398562211059086. Epub 2021 Dec 1.
5
Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers.芬太尼在狱中：合成阿片类药物对囚犯和狱警的影响。
Int J Drug Policy. 2019 Sep;71:133-138. doi: 10.1016/j.drugpo.2019.05.018. Epub 2019 Jul 23.
6
Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.德国北莱茵-威斯特法伦州监狱内阿片类药物维持治疗的实施——自上而下的方法。
Subst Abuse Treat Prev Policy. 2020 Mar 10;15(1):21. doi: 10.1186/s13011-020-00262-w.
7
Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.州立监狱中阿片类药物使用障碍的药物治疗：曾被监禁者的观点。
Subst Abus. 2022;43(1):964-971. doi: 10.1080/08897077.2022.2060448.
8
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.对被监禁者阿片类药物使用障碍（MOUD）药物治疗的伦理分析。
Subst Abus. 2020;41(2):150-154. doi: 10.1080/08897077.2019.1695706. Epub 2019 Dec 4.
9
Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners.非阿片类药物耐受的即将获释囚犯的丁丙诺啡剂量诱导
Drug Alcohol Depend. 2015 Nov 1;156:133-138. doi: 10.1016/j.drugalcdep.2015.09.001. Epub 2015 Sep 7.
10
Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India.监禁期间影响药物使用的因素：对来自印度的阿片类药物依赖者的横断面研究。
J Subst Abuse Treat. 2016 Feb;61:13-7. doi: 10.1016/j.jsat.2015.08.009. Epub 2015 Sep 21.
引用本文的文献
1
Medication for opioid use disorder service delivery in carceral facilities: update and summary report.监狱设施中阿片类药物使用障碍服务提供的药物治疗：最新情况及总结报告
Health Justice. 2025 Feb 1;13(1):8. doi: 10.1186/s40352-025-00317-9.
2
Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System.澳大利亚新南威尔士州司法环境中与阿片类药物相关的危害及护理体验：来自国家救护车监测系统的证据
Harm Reduct J. 2025 Jan 15;22(1):8. doi: 10.1186/s12954-025-01154-7.
3
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.出狱后治疗阿片类药物使用障碍的药物治疗连续性：一项基于社区的治疗提供者的定性研究。
Int J Drug Policy. 2022 Dec;110:103803. doi: 10.1016/j.drugpo.2022.103803. Epub 2022 Aug 11.
本文引用的文献
1
Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada.比较加拿大联邦男性矫正人群中不同阿片类药物激动剂治疗方式的特征和结果。
Int J Drug Policy. 2022 Feb;100:103480. doi: 10.1016/j.drugpo.2021.103480. Epub 2021 Oct 14.
2
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.在羁押环境中使用长效丁丙诺啡（CAM2038）治疗阿片类药物依赖。
Addiction. 2022 Feb;117(2):382-391. doi: 10.1111/add.15627. Epub 2021 Jul 16.
3
Fentanyl-related overdose during incarceration: a comprehensive review.监禁期间与芬太尼相关的过量用药：一项全面综述。
Health Justice. 2021 May 19;9(1):13. doi: 10.1186/s40352-021-00138-6.
4
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.每周和每月皮下注射长效纳曲酮与每日舌下含服丁丙诺啡治疗阿片类药物依赖的患者报告结局：一项随机临床试验。
JAMA Netw Open. 2021 May 3;4(5):e219041. doi: 10.1001/jamanetworkopen.2021.9041.
5
Risk of overdose-related death for people with a history of incarceration.有入狱史人群的药物过量相关死亡风险。
Addiction. 2021 Jun;116(6):1460-1471. doi: 10.1111/add.15293. Epub 2020 Nov 27.
6
Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.在澳大利亚新南威尔士州新冠疫情早期，拘留场所中丁丙诺啡长效注射剂（CAM2038）的快速推广。
Addiction. 2021 Feb;116(2):426-427. doi: 10.1111/add.15244. Epub 2020 Sep 21.
7
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.《在刑事司法系统中实施治疗阿片类药物使用障碍药物的障碍和促进因素的范围综述》。
Int J Drug Policy. 2020 Jul;81:102768. doi: 10.1016/j.drugpo.2020.102768. Epub 2020 May 20.
8
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?非故意药物过量：非处方丁丙诺啡使用频率增加是否与更低的过量风险相关？
Int J Drug Policy. 2020 Apr 17;79:102722. doi: 10.1016/j.drugpo.2020.102722.
9
Fentanyl behind bars: The implications of synthetic opiates for prisoners and correctional officers.芬太尼在狱中：合成阿片类药物对囚犯和狱警的影响。
Int J Drug Policy. 2019 Sep;71:133-138. doi: 10.1016/j.drugpo.2019.05.018. Epub 2019 Jul 23.
10
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.在全州监狱系统实施药物成瘾治疗后，监禁后的致命过量。
JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.
Zotero 插件